{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:14:08Z","timestamp":1648991648617},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s10165-011-0546-0","type":"journal-article","created":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T13:38:58Z","timestamp":1319463538000},"page":"571-575","source":"Crossref","is-referenced-by-count":1,"title":["The role of resistin in Beh\u00e7et\u2019s disease: a Turkish experiment"],"prefix":"10.1093","volume":"22","author":[{"given":"Yavuz","family":"Pehlivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Mesut","family":"Onat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seydi","family":"Okumu\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bunyamin","family":"Kisacik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gazi","family":"Comez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul","family":"Comez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Goktepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurdan Ozlu","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,10,25]]},"reference":[{"key":"546_CR1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00296-009-1123-0","volume":"30","author":"T Babacan","year":"2010","unstructured":"Babacan T, Onat AM, Pehlivan Y, Comez G, Tutar E. A case of the Beh\u00e7et\u2019s disease diagnosed by the panniculits after mesotherapy. Rheumatol Int. 2010;30:1657\u20139.","journal-title":"Rheumatol Int"},{"key":"546_CR2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/ard.60.11.996","volume":"60","author":"H Direskeneli","year":"2001","unstructured":"Direskeneli H. Beh\u00e7et\u2019s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis. 2001;60:996\u20131002.","journal-title":"Ann Rheum Dis"},{"key":"546_CR3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.iy.07.040189.003205","volume":"7","author":"B Beutler","year":"1989","unstructured":"Beutler B, Cerami A. The biology of cachectin\/TNF-A primary mediator of the host response. Annu Rev Immunol. 1989;7:625\u201355.","journal-title":"Annu Rev Immunol"},{"key":"546_CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2249.1996.tb08292.x","volume":"103","author":"G Bouma","year":"1996","unstructured":"Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, Von Blomberg BM, et al. Distribution of four polymorphisms in the tumor necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol. 1996;103:391\u20136.","journal-title":"Clin Exp Immunol"},{"key":"546_CR5","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","volume":"36","author":"MJ Elliott","year":"1993","unstructured":"Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 1993;36:1681\u201390.","journal-title":"Arthritis Rheum"},{"key":"546_CR6","first-page":"321","volume":"23","author":"N Sayinalp","year":"1996","unstructured":"Sayinalp N, Oezcebe OI, Oezdemir O, Haznedaroglu CH, Dundar S, Kirazli S. Cytokines in Beh\u00e7et\u2019s disease. J Rheumatol. 1996;23:321\u20132.","journal-title":"J Rheumatol"},{"key":"546_CR7","first-page":"1544","volume":"20","author":"JL Mege","year":"1993","unstructured":"Mege JL, Dilsen N, Sanguedolace V, Gul A, Bongrand P, Roux H, et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Beh\u00e7et\u2019s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993;20:1544\u20139.","journal-title":"J Rheumatol"},{"key":"546_CR8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbrc.2003.07.003","volume":"309","author":"S Kaser","year":"2003","unstructured":"Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 2003;309:286\u201390.","journal-title":"Biochem Biophys Res Commun"},{"key":"546_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clim.2009.07.013","volume":"133","author":"M Filkov\u00e1","year":"2009","unstructured":"Filkov\u00e1 M, Haluz\u00edk M, Gay S, Senolt L. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol. 2009;133:157\u201370.","journal-title":"Clin Immunol"},{"key":"546_CR10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/ard.2006.054734","volume":"66","author":"L Senolt","year":"2007","unstructured":"Senolt L, Housa D, Vernerov\u00e1 Z, Jir\u00e1sek T, Svobodov\u00e1 R, Veigl D, et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis. 2007;66:458\u201363.","journal-title":"Ann Rheum Dis"},{"key":"546_CR11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3129\/i08-081","volume":"43","author":"FN Yal\u00e7indag","year":"2008","unstructured":"Yal\u00e7indag FN, Yal\u00e7indag A, Batioglu F, Caglayan O, Kisa U, Ozdemir O. Evaluation of serum resistin levels in patients with ocular and non-ocular Beh\u00e7et\u2019s disease. Can J Ophthalmol. 2008;43:473\u20135.","journal-title":"Can J Ophthalmol"},{"key":"546_CR12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.arcmed.2010.05.008","volume":"41","author":"SK Kim","year":"2010","unstructured":"Kim SK, Choe JY, Park SH, Lee SW, Lee GH, Chung WT. Increased insulin resistance and serum resistin in Korean patients with Beh\u00e7et\u2019s disease. Arch Med Res. 2010;41:269\u201374.","journal-title":"Arch Med Res"},{"key":"546_CR13","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease (ISGBD)","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (ISGBD). Criteria for diagnosis of Behet\u2019s disease. Lancet. 1990;335:1078\u201380.","journal-title":"Lancet"},{"key":"546_CR14","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.4049\/jimmunol.174.9.5789","volume":"174","author":"M Bokarewa","year":"2005","unstructured":"Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174:5789\u201395.","journal-title":"J Immunol"},{"key":"546_CR15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5507\/bp.2003.009","volume":"147","author":"D Stejskal","year":"2003","unstructured":"Stejskal D, Adamovska S, Bartek J, Jurakova R, Proskova J. Resistin-concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003;147:63\u20139.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"546_CR16","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","volume":"111","author":"MP Reilly","year":"2005","unstructured":"Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis inhumans. Circulation. 2005;111:932\u20139.","journal-title":"Circulation"},{"key":"546_CR17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/sj.ki.5000089","volume":"69","author":"J Axelsson","year":"2006","unstructured":"Axelsson J, Bergsten A, Qureshi AR, Heimb\u00fcrger O, B\u00e1r\u00e1ny P, L\u00f6nnqvist F, et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int. 2006;69:596\u2013604.","journal-title":"Kidney Int"},{"key":"546_CR18","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.ijo.0803037","volume":"29","author":"S Bo","year":"2005","unstructured":"Bo S, Gambino R, Pagani A, Guidi S, Gentile L, Cassader M, et al. Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes (Lond). 2005;29:1315\u201320.","journal-title":"Int J Obes (Lond)"},{"key":"546_CR19","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.2337\/diacare.27.10.2450","volume":"27","author":"GK Shetty","year":"2004","unstructured":"Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistin levels in relation tometabolic factors, inflammatory markers, and vascular reactivityin diabetic patients and subjects at risk for diabetes. Diabetes Care. 2004;27:2450\u20137.","journal-title":"Diabetes Care"},{"key":"546_CR20","doi-asserted-by":"crossref","unstructured":"Al-Daghri N, Chetty R, McTernan PG, Al-Rubean K, Al-Attas O, Jones AF, et al. Serum resistin isassociated with c-reactive protein & LDL cholesterol in type 2diabetes and coronary artery disease in a Saudi population.Cardiovasc Diabetol. 2005;4:10.","DOI":"10.1186\/1475-2840-4-10"},{"key":"546_CR21","first-page":"311","volume":"26","author":"MA Gonzalez-Gay","year":"2008","unstructured":"Gonzalez-Gay MA, Garcia-Unzueta MT, Gonzalez-Juanatey C, Miranda-Filloy JA, Vazquez-Rodriguez TR, De Matias JM, et al. Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2008;26:311\u20136.","journal-title":"Clin Exp Rheumatol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0546-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:26Z","timestamp":1646843126000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0546-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,25]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["546"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0546-0","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,25]]}}}